The cell surface marker CD133 (also known as prominin-1) is a five-domain transmembrane molecule, and has been identified as a putative CSC marker in various cancers, including brain tumors, prostate carcinoma and CRC [7-9]. The gene discussed is PROM1; the disease is brain neoplasm.